Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2363 (LINC02363) is a lincRNA gene found on chromosome 4q35.1[2]. Its transcripts do not encode proteins and are classified as long non-coding RNAs, which are typically over 200 nucleotides in length and do not overlap known protein-coding regions[1][3][9]. The precise molecular and biological functions of LINC02363 remain to be determined, but it is part of the growing class of lincRNAs implicated in regulating gene expression through various epigenetic and post-transcriptional mechanisms[3][5][7][9]. Early research links LINC02363 to disease states such as sepsis—where it may serve as a biomarker—and potentially lung injury and perinatal hypoxic-ischemic encephalopathy[6][8][10]. There are no known drugs targeting LINC02363, but it is of interest in ongoing studies of non-coding RNA biology and biomarker development.
Not applicable; no drugs targeting LINC02363 are reported. If its function as a biomarker or regulator is confirmed, mechanisms would likely involve modulation of gene expression processes[8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2363 (LINC02363).